CAS RN: 1383385-64-5
N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide
Product Availability
Choose a grade to view its available package options.
3 package records 3 with current stock 1 grade group
Grade
≥97% (3)
In stock only
Batch No. Package Availability Inquiry
Batchno.20260613
1g
In stock
Inquiry
Batchno.20251129
25g
In stock
Inquiry
Batchno.20250111
5g
In stock
Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 10g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1383385-64-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
10g
>97%
0
Out of Stock
Hong Kong
Inquiry
1383385-64-5 / N-pyridin-2-yl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
Standard CAS: 1383385-64-5
Multi CAS: No
Basic Information
copy
CAS
1383385-64-5 copy
Multi CAS
No copy
Molecular Formula
C18H21BN2O3 copy
Molecular Weight
324.200000 copy
Exact Mass
324.164523 copy
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC=C(C=C2)C(=O)NC3=CC=CC=N3 copy
InChI
InChI=1S/C18H21BN2O3/c1-17(2)18(3,4)24-19(23-17)14-10-8-13(9-11-14)16(22)21-15-7-5-6-12-20-15/h5-12H,1-4H3,(H,20,21,22) copy
InChIKey
BFQWQKOPPQDARN-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
24 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.33 copy
Rotatable bonds
3 copy
H-bond acceptors
4 copy
H-bond donors
1 copy
Molar refractivity
94.35 copy
TPSA
60.45 copy
LogP / Solubility
WLOGP
2.63 copy
MLOGP
2.33 copy
XLogP3
2.63 copy
Consensus LogP
2.53 copy
Log S (ESOL)
-3.68 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.12 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.31 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.83 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
2.5 copy
Safety & Transport
copy
GHS Hazard Statements
Not Classified
Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website. copy